Advances in IBD Care: Monitoring with Wearable Sensors (ReachMD)

Managing inflammatory bowel disease (IBD) is a challenge, with flare-ups and symptoms often unpredictable. But could a wearable device provide real-time monitoring and better disease management?

Dr. Shalini Prasad and Dr. Sriram Muthukumar, co-founders of EnLiSense, have developed an innovative wearable that tracks inflammation markers in IBD patients, offering continuous, non-invasive monitoring.

Dr. Prasad, Head of Bioengineering at the University of Texas at Dallas, and Dr. Muthukumar, CEO of EnLiSense, discuss how this technology could revolutionize patient care, allowing early detection of flare-ups and personalized treatment adjustments.